Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
RFK Jr.’s Ideas on Big Pharma and Food Align With Some of Trump’s Biggest Criticsnews2024-11-27T08:00:11+00:00November 27th, 2024|The New York Times|
A Kennedy no le gusta Ozempic, esto es lo que podría hacer al respectonews2024-11-26T08:00:57+00:00November 26th, 2024|The New York Times|
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Resultsnews2024-11-26T01:42:26+00:00November 26th, 2024|The New York Times|
Dr Martin Makary Chosen to Head the FDAnews2024-11-23T02:15:50+00:00November 23rd, 2024|The New York Times|
Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claimsnews2024-11-16T03:21:15+00:00November 16th, 2024|The New York Times|
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovationnews2024-11-09T01:04:06+00:00November 9th, 2024|The New York Times|
F.D.A. Wants to Pull Ineffective Decongestant From Storesnews2024-11-07T20:31:25+00:00November 7th, 2024|The New York Times|
From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Changenews2024-11-01T23:57:56+00:00November 1st, 2024|The New York Times|
States Revive Lawsuit to Sharply Curb Access to Abortion Pillnews2024-10-21T09:03:32+00:00October 21st, 2024|The New York Times|
